IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype.

A subset of colorectal cancers (CRCs) show simultaneous methylation of multiple genes; these tumors have the CpG island methylator phenotype (CIMP). CRCs with CIMP show a specific pattern of genetic alterations, including a high frequency of BRAF mutations and a low frequency of p53 mutations. We therefore hypothesized that genes inactivated by DNA methylation are involved in the BRAF- and p53-signaling pathways. Among those, we examined the epigenetic inactivation of insulin-like growth factor-binding protein 7 (IGFBP7) expression in CRCs. We found that in CRC cell lines, the silencing of IGFBP7 expression was correlated with high levels of DNA methylation and low levels of histone H3K4 methylation. Luciferase and chromatin immunoprecipitation assays in unmethylated cells revealed that p53 induces expression of IGFBP7 upon binding to a p53 response element within intron 1 of the gene. Treating methylated CRC cell lines with 5-aza-2'-deoxycytidine restored p53-induced IGFBP7 expression. Levels of IGFBP7 methylation were also significantly higher in primary CRC specimens than in normal colonic tissue (P < 0.001). Methylation of IGFBP7 was correlated with BRAF mutations, an absence of p53 mutations and the presence of CIMP. Thus, epigenetic inactivation of IGFBP7 appears to play a key role in tumorigenesis of CRCs with CIMP by enabling escape from p53-induced senescence.

[1]  Xinbin Chen,et al.  DEC1, a Basic Helix-Loop-Helix Transcription Factor and a Novel Target Gene of the p53 Family, Mediates p53-dependent Premature Senescence* , 2008, Journal of Biological Chemistry.

[2]  M. Tatematsu,et al.  Chemical genomic screening for methylation‐silenced genes in gastric cancer cell lines using 5‐aza‐2′‐deoxycytidine treatment and oligonucleotide microarray , 2006, Cancer science.

[3]  Michael R. Green,et al.  An elaborate pathway required for Ras-mediated epigenetic silencing , 2007, Nature.

[4]  Hua Li,et al.  Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas , 1998, Oncogene.

[5]  A. Seth,et al.  Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors , 2001, Oncogene.

[6]  Peter A. Jones,et al.  Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival , 2006, Proceedings of the National Academy of Sciences.

[7]  Yuichiro Sato,et al.  Strong suppression of tumor growth by insulin‐like growth factor‐binding protein‐related protein 1/tumor‐derived cell adhesion factor/mac25 , 2007, Cancer science.

[8]  S. Hirohashi,et al.  Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. , 2007, Carcinogenesis.

[9]  R. Dahiya,et al.  Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. , 2003, Cancer research.

[10]  S. Velasco-Miguel,et al.  Induction of the growth inhibitor IGF-binding protein 3 by p53 , 1995, Nature.

[11]  P. Laird,et al.  CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.

[12]  J. Jass,et al.  Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer , 2007, Modern Pathology.

[13]  J. Herman,et al.  CpG island methylator phenotype in colorectal cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  H. Yasumitsu,et al.  Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells. , 1994, Biochemical and biophysical research communications.

[15]  R. Bernards,et al.  Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence , 2006, Nature Cell Biology.

[16]  M. Toyota,et al.  Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation. , 2006, Cancer research.

[17]  Toshiharu Yamashita,et al.  Identification of SCN3B as a novel p53-inducible proapoptotic gene , 2004, Oncogene.

[18]  Minoru Toyota,et al.  Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer , 2007, Proceedings of the National Academy of Sciences.

[19]  J. Y. Chen,et al.  Heterogeneity of transcriptional activity of mutant p53 proteins and p53 DNA target sequences. , 1993, Oncogene.

[20]  J. Shay,et al.  BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.

[21]  M. Poot,et al.  Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. , 2002, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[22]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[23]  M. Toyota,et al.  Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. , 2008, Cancer research.

[24]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  T. Curran,et al.  Role of DNA 5-methylcytosine transferase in cell transformation by fos. , 1999, Science.

[26]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[27]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Minoo,et al.  Senescence and serration: a new twist to an old tale , 2006, The Journal of pathology.

[29]  T. Ushijima,et al.  Aberrant methylations in cancer cells: Where do they come from? , 2005, Cancer science.

[30]  M. Pacyna‐Gengelbach,et al.  Insulin‐like growth factor binding protein‐related protein 1 (IGFBP‐rP1) has potential tumour‐suppressive activity in human lung cancer , 2007, The Journal of pathology.

[31]  Eduardo Sontag,et al.  Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.

[32]  K. Kinzler,et al.  Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[34]  K. Kinzler,et al.  Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status , 2002, Nature.

[35]  D. Woods,et al.  Senescence of human fibroblasts induced by oncogenic Raf. , 1998, Genes & development.

[36]  Kohzoh Imai,et al.  The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer. , 2005, Gastroenterology.

[37]  J. Lin,et al.  Methylation patterns of IGFBP7 in colon cancer cell lines are associated with levels of gene expression , 2007, The Journal of pathology.

[38]  M. Vail,et al.  Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis , 2002, Oncogene.

[39]  Yusuke Nakamura,et al.  Identification of the interleukin 4 receptor alpha gene as a direct target for p73. , 2003, Cancer research.

[40]  W. Ruan,et al.  Reactivation of IGFBP7 by DNA demethylation inhibits human colon cancer cell growth in vitro , 2008, Cancer biology & therapy.

[41]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[42]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[43]  N. Ahuja,et al.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[45]  S. Hasegawa,et al.  Identification of cell‐binding site of angiomodulin (AGM/TAF/Mac25) that interacts with heparan sulfates on cell surface , 1999, Journal of cellular biochemistry.

[46]  Michael R. Green,et al.  Oncogenic BRAF Induces Senescence and Apoptosis through Pathways Mediated by the Secreted Protein IGFBP7 , 2008, Cell.

[47]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[48]  M. Toyota,et al.  Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer , 2007, Oncogene.

[49]  M. Toyota,et al.  Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers. , 2000, Cancer research.

[50]  S. Baylin,et al.  p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3 , 1995, Nature Genetics.

[51]  W. El-Deiry,et al.  Regulation of p53 downstream genes. , 1998, Seminars in cancer biology.